Barley β-glucan reduces blood cholesterol levels via interrupting bile acid metabolism

Br J Nutr. 2017 Nov;118(10):822-829. doi: 10.1017/S0007114517002835. Epub 2017 Nov 8.


Underlying mechanisms responsible for the cholesterol-lowering effect of β-glucan have been proposed, yet have not been fully demonstrated. The primary aim of this study was to determine whether the consumption of barley β-glucan lowers cholesterol by affecting the cholesterol absorption, cholesterol synthesis or bile acid synthesis. In addition, this study was aimed to assess whether the underlying mechanisms are related to cholesterol 7α hydroxylase (CYP7A1) SNP rs3808607 as proposed by us earlier. In a controlled, randomised, cross-over study, participants with mild hypercholesterolaemia (n 30) were randomly assigned to receive breakfast containing 3 g high-molecular weight (HMW), 5 g low-molecular weight (LMW), 3 g LMW barley β-glucan or a control diet, each for 5 weeks. Cholesterol absorption was determined by assessing the enrichment of circulating 13C-cholesterol over 96 h following oral administration; fractional rate of synthesis for cholesterol was assessed by measuring the incorporation rate of 2H derived from deuterium oxide within the body water pool into the erythrocyte cholesterol pool over 24 h; bile acid synthesis was determined by measuring serum 7α-hydroxy-4-cholesten-3-one concentrations. Consumption of 3 g HMW β-glucan decreased total cholesterol (TC) levels (P=0·029), but did not affect cholesterol absorption (P=0·25) or cholesterol synthesis (P=0·14). Increased bile acid synthesis after consumption of 3 g HMW β-glucan was observed in all participants (P=0·049), and more pronounced in individuals carrying homozygous G of rs3808607 (P=0·033). In addition, a linear relationship between log (viscosity) of β-glucan and serum 7α-HC concentration was observed in homozygous G allele carriers. Results indicate that increased bile acid synthesis rather than inhibition of cholesterol absorption or synthesis may be responsible for the cholesterol-lowering effect of barley β-glucan. The pronounced TC reduction in G allele carriers of rs3808607 observed in the previous study may be due to enhanced bile acid synthesis in response to high-viscosity β-glucan consumption in those individuals.

Keywords: β-Glucan; 7α-HC 7α-hydroxy-4-cholesten-3-one; CYP7A1 cholesterol 7α hydroxylase; FRS fractional rate of synthesis; HMW high-molecular weight; LWM low-molecular weight; MW molecular weight; TC total cholesterol; Bile acids; CYP7A1; Cholesterol; Mechanisms; Molecular weight; Viscosity.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Alleles
  • Bile Acids and Salts / metabolism*
  • Carbon Isotopes / blood
  • Cholestenones / blood
  • Cholesterol / biosynthesis
  • Cholesterol / blood*
  • Cholesterol 7-alpha-Hydroxylase / blood
  • Cholesterol 7-alpha-Hydroxylase / genetics*
  • Cholesterol, Dietary / blood
  • Cholesterol, LDL / blood
  • Cross-Over Studies
  • Dietary Fiber / pharmacology
  • Dietary Fiber / therapeutic use
  • Female
  • Genotype
  • Hordeum / chemistry*
  • Humans
  • Hypercholesterolemia / blood
  • Hypercholesterolemia / drug therapy
  • Hypercholesterolemia / metabolism*
  • Intestinal Absorption
  • Male
  • Middle Aged
  • Molecular Weight
  • Plant Extracts / pharmacology
  • Plant Extracts / therapeutic use
  • Polymorphism, Single Nucleotide*
  • beta-Glucans / pharmacology*
  • beta-Glucans / therapeutic use


  • Bile Acids and Salts
  • Carbon Isotopes
  • Cholestenones
  • Cholesterol, Dietary
  • Cholesterol, LDL
  • Dietary Fiber
  • Plant Extracts
  • beta-Glucans
  • 7 alpha-hydroxy-4-cholesten-3-one
  • Cholesterol
  • CYP7A1 protein, human
  • Cholesterol 7-alpha-Hydroxylase